B17_Thera_G8_091814

CHORLA BLOCK 17 Therapeutics (Sep. 18, 2014) Group 8 72/12. Basmayor: Standard parameter used for monitoring glycemic control A. Fasting blood sugar B. Hgb1c C. 2 hours postprandial glucose D. 4 hours postprandial glucose 73. Hidrosollo: (presenter) 74/14. Olac: Which increases risk factor for micro/macrovascular complications? A. Alcohol drinking B. Smoking*** C. 10hr workload D. Treadmill exercise 75. Villalobos: prescription  76. Bontia: prescription  77. King: prescription  78. Onglatco: prescription  79. Pestijo: prescription  80. Sameros: prescription  81/1. Vasquez: In the case, active monitoring will be done by A. Fasting blood glucose after 2 weeks *** B. HgbA1c after 2 weeks C. Fasting blood glucose after 2 months D. HgbA1c after 2 months